Back

Cardiovascular prognosis in hypertrophic cardiomyopathy: insights from cardiopulmonary exercise testing.

24 May 2016 (10:30 - 10:36)
Organised by:
Congress Presentation Part of: Moderated Poster Session 6 - Comorbidities Hypertrophic cardiomyopathy HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Matteo Casenghi

Sapienza University of Rome, Rome (Italy)

9 More presentations in this session

Presentation thumbnail
3-month survival of the improvement of functional capacity after in-hospital short courses of leg neuromuscular electric stimulation in patients with decompensated chronic heart failure
Professor M. Poltavskaya (Moscow, RU)
Abstract Slides
Presentation thumbnail
Prognostic value of right ventricular systolic function in cardiac amyloidosis
Doctor D. Bodez (Creteil, FR)
Abstract Slides
Presentation thumbnail
Estimated glomerular filtration rate formulas and acute heart failure: does it worth to complicate?
Doctor M. Madeira (Coimbra, PT)
Abstract
Presentation thumbnail
Ergoreflex overactivity in mitochondrial disease: linking skeletal myopathy to exercise intolerance, dysautonomia, and cardiac damage
Doctor A. Aimo (Pisa, IT)
Abstract Slides
Presentation thumbnail
Efficacy and safety of didpeptidyl peptidase 4 inhibitors in patients with type 2 diabetes mellitus: a meta-analysis of 116 trials
Doctor G. Savarese (Stockholm, SE)
Abstract Slides

Access the full session

Session thumbnail
Moderated Poster Session 6 - Comorbidities

The Event

Event poster

HEART FAILURE 2016

24 May 2016 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy.
27 August 2021
thumbnail
Congress Presentation
Physical exercise and hypertension
29 August 2025
thumbnail
Webinar
Hypertrophic cardiomyopathy - disease course and therapeutic strategies for patients
23 November 2021
thumbnail
Congress Presentation
The role of stress echocardiography to unmask latent LVOT obstruction in hypertrophic cardiomyopathy
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources